ioGenetics

ioGenetics is a private biotechnology company based in Madison, Wisconsin focused on infectious-disease therapeutics, vaccines, diagnostics, and immunoinformatics. The company describes an integrated recombinant-protein pipeline and has emphasized proprietary antimicrobial proteins, including anticryptosporidial, antistaphylococcal, and antiviral products. Its technology base appears to include the RPex retrovector platform for producing novel antibodies and antibody-fusion proteins, as well as immunoinformatics capabilities associated with uTOPE and its subsidiary EigenBio. Publicly available information suggests the company remains small, private, and primarily preclinical, with licensing and partnering interest around its protein technologies and intellectual property portfolio. ioGenetics appears best characterized as an early-stage platform-oriented biotech rather than a clinical-stage drug developer.